NCT03419962 - Greek NIS Spiolto ELLACTO | Biotech Hunter

Enrollment

1,360

Participants

Timeline

Start Date

March 19, 2018

Primary Completion Date

November 9, 2018

Study Completion Date

April 3, 2019

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

MaxSpiolto® Respimat® 160 Characters...

as per the approved SmPC

Trial Locations (15)

Metropolitan, Aegina

Metroplitan, Athens

Metropolitan, Athens

Metropolitan, Chania

Metropolitan, Heraklio

Metropolitan, Hrakleio

Metropolitan, Hraklio

Metropolitan, Pátrai

Merkouropoulos Markos, Thessaloniki

Diavalkaniko, Ioannina

Diavalkaniko, Kavala

Diavalkaniko, Larissa

Diavalkaniko, Serres

Diavalkaniko, Thessaloniki

Diavalkaniko, Volos